Hybrid Revascularization: A Review

Area of Science:

• Cardiovascular Surgery
• Interventional Cardiology
• Medical Technology

Background:

• Coronary artery bypass grafting using the left internal mammary artery (LIMA) is the gold standard for multivessel coronary artery disease due to superior long-term patency and survival.
• Saphenous vein grafts demonstrate poor long-term patency, limiting their effectiveness.
• Advances in percutaneous coronary intervention (PCI) stent technology have improved outcomes, making it a viable option for select patients.

Purpose of the Study:

• To explore hybrid coronary revascularization (HCR) as a less invasive alternative for coronary artery revascularization.
• To combine the established benefits of LIMA grafting with the advancements in PCI.
• To evaluate the potential of HCR in improving patient outcomes for multivessel coronary artery disease.

Main Methods:

• Hybrid coronary revascularization (HCR) involves combining surgical bypass (e.g., LIMA) with PCI.
• Procedures can be performed concurrently or in a staged approach within 60 days.
• Utilizes newer generation stents for PCI components.

Main Results:

• HCR presents an attractive, less invasive revascularization strategy.
• It aims to preserve the benefits of LIMA grafts.
• It incorporates the efficacy of modern stent technology for PCI.

Conclusions:

• Hybrid coronary revascularization is a promising approach for selected patients with multivessel coronary artery disease.
• This strategy synergizes the long-term patency of LIMA grafts with the efficacy of contemporary PCI.
• HCR offers a less invasive alternative while maintaining the benefits of established surgical and interventional techniques.